New Adjuvant Treatment of Locally Advanced Resectable Gastric Cancer With Carelizumab and XELOX
Condition(s):Gastric CancerLast Updated:July 14, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Gastric CancerLast Updated:July 14, 2023Recruiting
Condition(s):Biliary Tract TumorLast Updated:March 22, 2022Recruiting
Condition(s):Gastric CancerLast Updated:October 23, 2023Not yet recruiting
Condition(s):Colorectal NeoplasmsLast Updated:July 12, 2016Unknown status
Condition(s):Colon CancerLast Updated:April 19, 2022Not yet recruiting
Condition(s):Gastric Cancer/Gastroesophageal Junction AdenocarcinomaLast Updated:November 30, 2023Recruiting
Condition(s):Gastric CancerLast Updated:January 26, 2024Recruiting
Condition(s):First-line Treatment; Advanced Gastric CarcinomaLast Updated:February 3, 2022Unknown status
Condition(s):Colorectal Cancer Stage IVLast Updated:March 13, 2023Recruiting
Condition(s):Gastric CarcinomaLast Updated:July 26, 2018Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.